Literature DB >> 15094515

A critical role for beta-endorphin in cocaine-seeking behavior.

I Roth-Deri1, C J Schindler, G Yadid.   

Abstract

Endogenous beta-endorphin levels in the brain are elevated in response to cocaine and are downstream of the mesolimbic dopaminergic system. However, beta-endorphin's direct involvement in cocaine reinforcement has not been demonstrated. In the present study, a single bilateral microinjection of anti-beta-endorphin antibodies (4 microg) to the nucleus accumbens during the maintenance phase of cocaine self-administration (1 mg/kg/infusion) significantly increased the number of active and inactive lever responses. The increase in lever responses is reminiscent of rat behavior during extinction of cocaine self-administration. Further, a cocaine dose-response demonstrates that the increased lever presses in anti-beta-endorphin antibody-injected rats was still present after substitution with a lower dose of cocaine. These findings support a critical role for beta-endorphin in the cocaine brain reward system. Copyright 2004 Lippincott Williams & Wilkins

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094515     DOI: 10.1097/00001756-200403010-00027

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  12 in total

Review 1.  Microdialysis as a tool in local pharmacodynamics.

Authors:  Yanjun Li; Joanna Peris; Li Zhong; Hartmut Derendorf
Journal:  AAPS J       Date:  2006-04-07       Impact factor: 4.009

2.  β-endorphin via the delta opioid receptor is a major factor in the incubation of cocaine craving.

Authors:  Yahav Dikshtein; Royi Barnea; Noam Kronfeld; Elad Lax; Ilana Roth-Deri; Alexander Friedman; Iris Gispan; Einat Elharrar; Sarit Levy; Moshe Ben-Tzion; Gal Yadid
Journal:  Neuropsychopharmacology       Date:  2013-06-26       Impact factor: 7.853

3.  Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse.

Authors:  Sarah Sushchyk; Zheng-Xiong Xi; Jia Bei Wang
Journal:  J Pharmacol Exp Ther       Date:  2016-02-22       Impact factor: 4.030

4.  Sucrose self-administration and CNS activation in the rat.

Authors:  Dianne P Figlewicz; Jennifer L Bennett-Jay; Sepideh Kittleson; Alfred J Sipols; Aryana Zavosh
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-02-09       Impact factor: 3.619

5.  Disruption of GABA or glutamate release from POMC neurons in the adult mouse does not affect metabolic end points.

Authors:  Andrew R Rau; Connie M King; Shane T Hentges
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-09-16       Impact factor: 3.619

6.  Differential peptidomics assessment of strain and age differences in mice in response to acute cocaine administration.

Authors:  Elena V Romanova; Stanislav S Rubakhin; John R Ossyra; Jonathan A Zombeck; Michael R Nosek; Jonathan V Sweedler; Justin S Rhodes
Journal:  J Neurochem       Date:  2015-08-25       Impact factor: 5.372

7.  The role of beta-endorphin in the acute motor stimulatory and rewarding actions of cocaine in mice.

Authors:  Paul Marquez; Ramkumarie Baliram; Ibrahim Dabaja; Nagaraju Gajawada; Kabirullah Lutfy
Journal:  Psychopharmacology (Berl)       Date:  2008-01-06       Impact factor: 4.530

Review 8.  The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction.

Authors:  Kabirullah Lutfy; Nurulain T Zaveri
Journal:  Prog Mol Biol Transl Sci       Date:  2015-12-23       Impact factor: 3.622

9.  The rewarding action of acute cocaine is reduced in β-endorphin deficient but not in μ opioid receptor knockout mice.

Authors:  Alexander T Nguyen; Paul Marquez; Abdul Hamid; Brigitte Kieffer; Theodore C Friedman; Kabirullah Lutfy
Journal:  Eur J Pharmacol       Date:  2012-05-02       Impact factor: 4.432

10.  Role of mu- and delta-opioid receptors in the nucleus accumbens in cocaine-seeking behavior.

Authors:  Diana Simmons; David W Self
Journal:  Neuropsychopharmacology       Date:  2009-03-11       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.